Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 145.00
-4.00 (-2.68%)
Aug 12, 2026, 11:24 AM GMT
Diaceutics Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 126 | 108 | 106 | 73 | 63 | 85 | |
Market Cap Growth | 8.77% | 2.16% | 45.15% | 15.15% | -25.76% | -17.42% |
Enterprise Value | 120.28 | 102.17 | 94.39 | 57.62 | 44.95 | 67.36 |
Last Close Price | 1.45 | 1.28 | 1.25 | 0.87 | 0.76 | 1.02 |
PE Ratio | 1303.84 | 1163.64 | - | - | 89.88 | 154.54 |
Forward PE | 179.52 | 49.23 | 24.77 | 24.77 | 30.32 | 40.80 |
PS Ratio | 3.29 | 2.82 | 3.30 | 3.08 | 3.25 | 6.13 |
PB Ratio | 3.12 | 2.68 | 2.66 | 1.79 | 1.49 | 2.10 |
P/TBV Ratio | 5.06 | 4.47 | 4.34 | 2.87 | 2.38 | 3.11 |
P/FCF Ratio | 114.14 | 97.80 | 192.51 | 61.62 | 12.93 | 17095.80 |
P/OCF Ratio | 107.27 | 91.91 | 162.94 | 55.74 | 12.45 | 149.96 |
EV/Sales Ratio | 3.13 | 2.66 | 2.94 | 2.43 | 2.30 | 4.83 |
EV/EBITDA Ratio | 20.54 | 17.45 | 43.46 | 32.83 | 12.55 | 28.68 |
EV/EBIT Ratio | 2797.22 | 2376.12 | - | - | 78.18 | 122.48 |
EV/FCF Ratio | 108.56 | 92.21 | 171.31 | 48.58 | 9.15 | 13473.00 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
Debt / EBITDA Ratio | 0.20 | 0.20 | 0.49 | 0.69 | 0.37 | 0.67 |
Debt / FCF Ratio | 1.04 | 1.04 | 1.92 | 1.02 | 0.27 | 312.20 |
Net Debt / Equity Ratio | -0.15 | -0.15 | -0.29 | -0.38 | -0.43 | -0.45 |
Net Debt / EBITDA Ratio | -1.06 | -1.06 | -5.38 | -8.81 | -5.17 | -7.71 |
Net Debt / FCF Ratio | -5.59 | -5.59 | -21.20 | -13.04 | -3.77 | -3622.80 |
Asset Turnover | 0.78 | 0.78 | 0.68 | 0.50 | 0.42 | 0.31 |
Quick Ratio | 3.43 | 3.43 | 3.80 | 6.40 | 8.23 | 11.41 |
Current Ratio | 3.43 | 3.43 | 3.80 | 6.40 | 8.23 | 11.41 |
Return on Equity (ROE) | 0.24% | 0.24% | -4.22% | -4.19% | 1.74% | 1.39% |
Return on Assets (ROA) | 0.03% | 0.03% | -4.61% | -4.57% | 1.58% | 1.51% |
Return on Invested Capital (ROIC) | 0.04% | 0.04% | -8.19% | -8.76% | 3.17% | 3.55% |
Return on Capital Employed (ROCE) | 0.10% | 0.10% | -5.93% | -6.98% | 1.32% | 1.33% |
Earnings Yield | 0.08% | 0.09% | - | - | 1.11% | 0.65% |
FCF Yield | 0.88% | 1.02% | 0.52% | 1.62% | 7.74% | 0.01% |
Buyback Yield / Dilution | -0.80% | -0.80% | -0.27% | 2.16% | -1.35% | -9.14% |
Total Shareholder Return | -0.80% | -0.80% | -0.27% | 2.16% | -1.35% | -9.14% |